[en] The example of the analysis of a collection of trials in diabetes consisting of a sparsely connected network of 10 treatments is used to make some points about approaches to analysis. In particular various graphical and tabular presentations, both of the network and of the results are provided and the connection to the literature of incomplete blocks is made. It is clear from this example that is inappropriate to treat the main effect of trial as random and the implications of this for analysis are discussed. It is also argued that the generalisation from a classic random-effect meta-analysis to one applied to a network usually involves strong assumptions about the variance components involved. Despite this, it is concluded that such an analysis can be a useful way of exploring a set of trials.
Disciplines :
Mathematics Endocrinology, metabolism & nutrition
Author, co-author :
Senn, S
Gavini, F
Magrez, D
SCHEEN, André ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Eddy DM, Hasselblad V, Schacker R. An introduction to a Bayesian method for Meta-analysis: the confidence profile method. Med Decis Making. 1991 ; 10: 15-23 (Pubitemid 20086092)
Chung H, Lumley T. Graphical exploration of network meta-analysis data: the use of multidimensional scaling. Clin Trials. 2008 ; 5 (4). 301-307
Thijs V, Lemmens R, Fieuws S. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke. Eur Heart J. 2008 ; 29 (9). 1086-1092 (Pubitemid 351844879)
Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002 ; 21 (16). 2313-2324
Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003 ; 326 (7387). 472-472
Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007 ; 369 (9557). 201-207 (Pubitemid 46111014)
Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004 ; 23 (20). 3105-3124 (Pubitemid 39334902)
Lu G, Ades AE, Sutton AJ, Cooper NJ, Briggs AH, Caldwell DM. Meta-analysis of mixed treatment comparisons at multiple follow-up times. Stat Med. 2007 ; 26 (20). 3681-3699 (Pubitemid 47307743)
Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005 ; 331 (7521). 897-900 (Pubitemid 41502718)
Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Meth Med Res. 2008 ; 17 (3). 279-301
Fisher LD, Gent M, Buller HR. Active-control trials: how would a new agent compare with placebo? A method illustrated clopidogrel, aspirin, and placebo. Am Heart J. 2001 ; 141 (1). 26-32 (Pubitemid 32061308)
Hasselblad V, Kong DF. Statistical methods for comparison to placebo in active-control studies. Drug Inform J. 2001 ; 35: 435-449 (Pubitemid 32524896)
Hirotsu C, Yamada L. Estimating odds ratios through the connected comparative experiments. Commun Stat Theory Meth. 1999 ; 28 (3-4). 905-929
Senn SJ. 'Equivalence is different' - Some comments on therapeutic equivalence. Biometr J. 2005 ; 47 (1). 104-107
Yates F. Incomplete randomized blocks. Ann Eugenics. 1936 ; 7: 121-140
Yates F. A new method for arranging variety trials involving a large number of varieties. J Agricult Sci. 1936 ; 26: 424-455
Hinkelmann K, Kempthorne O Design and analysis of experiments: advanced experimental design. Hobokken: Wiley ; 2005 :
Yates F. The recovery of inter-block information in variety trials arranged in three-dimensional lattices. Ann Eugenics. 1939 ; 9: 136-156
Aitken AC. On least-squares and linear combinations of observations. Proc Roy Soc Edinburgh. 1934 ; 55: 42-48
Senn S. Hans van Houwelingen and the art of summing up. Biometr J. 2010 ; 52 (1). 85-94
International Conference on Harmonisation. ICH harmonised tripartite guideline: choice of control group and related issues in clinical trials. In: International Conference on Harmonisation, 20 July 2000.
Farkouh ME, Kirshner H, Harrington RA, Ruland S, Verheugt FW, Schnitzer TJ, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet. 2004 ; 364 (9435). 675-684 (Pubitemid 39140623)
Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet. 2004 ; 364 (9435). 665-674 (Pubitemid 39140622)
Senn S. Lessons from TGN1412 and TARGET: implications for observational studies and meta-analysis. Pharm Stat 2008; 7(4): 294-301.
Hsu JC Multiple comparisons theory and methods. Boca Raton: Chapman & Hall/CRC ; 1996 :
Fisher RA. Contribution to a discussion of J. Neyman's paper on statistical problems in agricultural experimentation. J Roy Stat Soc. 1935 ; 2: 154-157
Senn SJ. Added values: Controversies concerning randomization and additivity in clinical trials. Stat Med. 2004 ; 23 (24). 3729-3753
Senn SJ. The many modes of meta. Drug Inform J. 2000 ; 34: 535-549
Ruhkin A. Two procedures of meta-analysis in clinical trials and interlaboratory studies. Tatra Mountains Math Publ. 2003 ; 26: 155-168
DerSimonian R, Laird N. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007 ; 28: 105-114
McCullagh P, Nelder JA Generalized linear models. 2 nd edn. London: Chapman and Hall, 1989. London: Chapman and Hall ; 1989 :
Senn SJ Statistical issues in drug development. 2 nd edn. Hoboken: Wiley, 2007. Hoboken: Wiley ; 2007 :
Senn SJ. Trying to be precise about vagueness. Stat Med. 2007 ; 26: 1417-1430
Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value Health. 2011 ; 14 (4). 429-437
Thompson SG. Systematic review - why sources of heterogeneity in metaanalysis should be investigated. Br Med J. 1994 ; 309 (6965). 1351-1355 (Pubitemid 24345976)
Feige G, Leutert T, De Pover A. Na,K-ATPase isozymes in rat tissues: differential sensitivities to sodium, vanadate and dihydroouabain. Prog Clin Biol Res. 1988 ; 268B: 377-384
Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diab Obes Metabol. 2007 ; 9 (5). 733-745 (Pubitemid 47261855)
Royall R The nature of scientific evidence. Taper ML Lele SR, ed. Chicago: University of Chicago Press ; 2004: 119-138.
Julious S, Wang SJ. How biased are indirect comparisons, particularly when comparisons are made over time in controlled trials. Drug Inform J. 2008 ; 42 (6). 625-633
Chapell R, Gould AL, Alexander CM. Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone. Diab Obes Metab. 2009 ; 11 (11). 1009-1016
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
